A, LOH on chromosome 17q (D17S785; expected size, 181–207 bp) in SC-IDC (Lane 2), SC-DCIS (Lane 3), clear-cut normal epithelial cells (Lane 4), DCIS (Lane.

Slides:

Advertisements

Similar presentations

Homozygous deletions within chromosome 9q23.

Advertisements

Copyright © 2003 American Medical Association. All rights reserved.

(B.P :51) ( B:P52 ).

IDH1 mutant glioma cells are sensitive to TMZ

IL-1β differentially regulates CXCL5 and CXCL8 protein secretion in NHTBE and NSCLC cells. IL-1β differentially regulates CXCL5 and CXCL8 protein secretion.

Rearrangements of Gene A and Gene B

Life expectancy and baseline BP: Male participants

Distribution of informative SNPs with LOH (black bars) on each chromosome (rows, oriented p-arm at the bottom and q-arm at the top of each chromosome)

ROC curve for separating advanced stages (advanced BE and EA) versus early stages (BE or BE instability) using total genome-wide LOH [area under the curve.

Number of 0.5-Mb windows with chromosome lesions that reached statistical significance across patients in early (BE early and BE instability) and late.

Chromosome 8 cDNA microarray gene expression profile of the amplified regions of 8p11–12 in SUM-44, -52, and -225 cells versus MCF10A HME control cells.

A, genomic copy number profiles of chromosome 8 with array CGH in SUM-44, -52, and A, genomic copy number profiles of chromosome 8 with array CGH.

NICD1 immunohistochemical staining in normal and tumor tissue.

Possible sites of action of aspirin in the prevention of colorectal cancer. Possible sites of action of aspirin in the prevention of colorectal cancer.

Immunoperoxidase stainings for HLA-DR (A and B) and HLA-DP (C and D) in jejunal biopsy specimens from a healthy control (A and C) and from a type 1 diabetic.

SIRT1 is downregulated in human gastric cancer (GC).

Knockdown of endogenous WT-hTER by a short hairpin RNA (siRNA) directed specifically against the human WT telomerase RNA template. Knockdown of endogenous.

Induction of apoptosis by NMT siRNAs.

A, B, apoptosis analysis using Annexin V-FITC/PI was done on 5th, 7th, and 9th day after transfection either with si control or si AEBP1in U87MG and U138MG.

FAK overexpression in invasive human breast cancer and DCIS

BME treatment increases granzyme B expression in NK 3.3 cells.

Colony-forming capacity of CD34+ cells with and without CLL-1 expression. Colony-forming capacity of CD34+ cells with and without CLL-1 expression. CD34+

Reduced BAI1 expression is associated with breast cancer patient survival. Reduced BAI1 expression is associated with breast cancer patient survival. A,

pRb turnover in melanoma cells and normal melanocytes.

Anti-Flk-1 treatment inhibits growth of s. c. 4T1 and B16 tumors. s. c

Matriptase-2 inhibited breast tumor development in vivo.

Electron microscopy. Electron microscopy. A, 8 h after irradiation. An endothelial cell is seen protruding into the lumen of the vessel. Arrow head, a.

The I1307K APC gene variant was identified using primers designed to detect the I1307K. The I1307K APC gene variant was identified using primers designed.

MPGES is expressed in epithelial cells in benign and malignant tumors of the colon. mPGES is expressed in epithelial cells in benign and malignant tumors.

Induction of a tumor-specific immune response following radiofrequency ablation (RFA). Induction of a tumor-specific immune response following radiofrequency.

Expression pattern of TLR-4 and MyD88 in EOC cells.

T-cell activation and induction of apoptosis in epithelial cells of oral lesions induced by 4-NQO. T-cell activation and induction of apoptosis in epithelial.

Synergistic cytotoxicity of 17AAG and TNF treatment in human lung cancer cell lines. Synergistic cytotoxicity of 17AAG and TNF treatment in human lung.

Uptake of TEX by DCs in vivo.

GR CAFs modulate the EGFR-TKI response in cocultured tumor cells.

Detection of PSA-mRNA by single (first panel, 710 bp) and nested (second panel, 455 bp) RT-PCR. Detection of PSA-mRNA by single (first panel, 710 bp) and.

Northern blot analysis of maspin in cancer cell lines and human tissues. Northern blot analysis of maspin in cancer cell lines and human tissues. A, HMECs.

SBC-5 miR-335+, but not SBC-5 miR-29a+, exhibited reduced IGF-IR expression. SBC-5 miR-335+, but not SBC-5 miR-29a+, exhibited reduced IGF-IR expression.

Ligation efficiency is abrogated with increasing concentration of antibodies against NHEJ proteins. Ligation efficiency is abrogated with increasing concentration.

Representative photograph of somatic mutations detected by PCR-SSCP.

WP1066 inhibits the progression of OCIM2 cells through the cell cycle.

Methylation-specific PCR of APC, RASSF1A, and p14ARF genes in bladder tumor and urine DNAs. In the APC gel panel viewed from left to right, the first (TCC34)

Distribution of FGFR aberrancies in urothelial cancers.

Reduced klotho expression in pancreatic cancer.

Characterization of DNA-PK and PARP-1 levels and activities in the cell lines studied. Characterization of DNA-PK and PARP-1 levels and activities in the.

Representative images demonstrating LOH in breast cancer patients’ paired BM aspirate and primary tumors (T) at D14S62, D14S51, and D8S321, respectively.

Activation status of CD8+ T cells.

Effects of UVB on AKT in SKH-1 mouse epidermis.

ROC analysis of MIC-1 and CA19-9.

Progastrin staining in colon adenomas and adenocarcinomas.

Immunoblot analysis in PANC1 and MSTO-211H cells.

SAHA blocks IR-induced increase of RAD51 protein in MM cells.

Single nucleotide polymorphism array analysis can distinguish different genetic mechanisms that lead to loss of heterozygosity (LOH). Single nucleotide.

AKT activation in HCC2429 is SRC- but not Notch-dependent.

Proliferation of TA3-Ha and TA3-St cells in vitro and in vivo.

Reduced expression of the tumor suppressor PTEN occurs in tumors with both squamous cell and adenocarcinoma histology. Reduced expression of the tumor.

A, Proportion for different in silico predictions at the RNA level.

Flavopiridol inhibits rhabdoid cell survival and induces cell cycle arrest and apoptosis. Flavopiridol inhibits rhabdoid cell survival and induces cell.

ABT-888 sensitizes multiple ovarian cancer cell lines but not normal cells to FdUrd. ABT-888 sensitizes multiple ovarian cancer cell lines but not normal.

T-cell expression of second-generation CARs

Regression analysis showing the positive correlation between number of months since the prior chemotherapy regimen (X axis) and the difference between.

Expression of chemokine receptors in A-498 cell line.

Relative frequencies of FGFR aberrations in non–small cell lung carcinoma. Relative frequencies of FGFR aberrations in non–small cell lung carcinoma. A,

Depleting NQO1 expression levels inhibits growth of NSCLC cells in soft agar. Depleting NQO1 expression levels inhibits growth of NSCLC cells in soft agar.

Phenotypic diversity of less predominant B-lineage clones.

Loss of NQO1 expression inhibits invasion of NSCLC

Knockdown of ROR1 increases the invasive potential of melanoma cells in vitro and in vivo. Knockdown of ROR1 increases the invasive potential of melanoma.

Determination of Per2 (left), MTNR1A (middle), and ERβ (right) protein expression levels in mammary tissues of rats sacrificed at ZT12. Determination of.

Epithelial and stromal percentage clusterin staining in normal nonadjacent colonic tissue and matched tumor tissue in 202 patients with stage II colorectal.

CONSORT diagram. a, 5 had a major treatment violation (3 refused and 2 received wrong treatment) but were included in the analyses; b, 4 had a major treatment.

Presentation transcript:

A, LOH on chromosome 17q (D17S785; expected size, 181–207 bp) in SC-IDC (Lane 2), SC-DCIS (Lane 3), clear-cut normal epithelial cells (Lane 4), DCIS (Lane 5), and IDC (Lane 6). A, LOH on chromosome 17q (D17S785; expected size, 181–207 bp) in SC-IDC (Lane 2), SC-DCIS (Lane 3), clear-cut normal epithelial cells (Lane 4), DCIS (Lane 5), and IDC (Lane 6). Lane 1, normal SAD from DCIS or IDC. B, graphical (densitometric) representation of lanes seen in A. Farid Moinfar et al. Cancer Res 2000;60:2562-2566 ©2000 by American Association for Cancer Research